Selected Publications

Ingelfinger F*, Gerdes LA*, Kavaka V, Krishnarajah S, Friebel E, Galli E, Zwicky P,
Furrer R, Peukert C, Dutertre CA, Eglseer KM, Ginhoux F, Flierl-Hecht A, Kümpfel T, De Feo D, Schreiner B, Mundt S, Kerschensteiner M, Hohlfeld R , Beltrán E#, Becher B#. (2022) Twin
study reveals non-heritable immune perturbations in multiple sclerosis. Nature. 

Ingelfinger F, Levy N, Ergen C, Bakulin A, Becker A, Boyeau P, Kim M, Ditz D, Dirks J, Maaskola J, Wertheimer T, Zeiser R, Widmer C, Amit I#, Yosef N#. (2025) CytoVI: Deep generative modeling of antibody-based single cell technologies. BioRxiv. 

Kirschenbaum D*, Xie K*, Ingelfinger F*, Katzenelenbogen Y*, Abadie K*, Look T,
Sheban F, Phan TS, Li B, Zwicky P, Yofe I, David E, Mazuz K, Hou J, Chen Y, Shaim H, Shanley M, Becker S, Qian J, Colonna M, Ginhoux F, Rezvani K, Theis FJ, Yosef N, Weiss T, Weiner A#, Amit I#. (2024) Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma. Cell. 

Sheban F*, Truong SP*, Xie K*, Ingelfinger F*, Gur C, Shapir Y, Shapir I, Blecher-
Gonen R, Yu C, Avellino R, Chalan P, Freitag K, Yofe I, Yutkin V, Boyeau P, Ergen C, Hong J,
Mazuz K, Liu Y, Chen K, Dahan R, Kortylewski M, Yosef N, Weiner A, Amit I. (2025) ZEB2 is a master switch controlling the tumor-associated macrophage program. Cancer Cell.

Andreadou M*, Ingelfinger F*, De Feo D$, Cramer T$, Tuzlak S$, Friebel E, Schreiner
B, Eede P, Schneeberger S, Geesdorf M, Ridder F, Welsh C, Power L, Kirschenbaum D,
Tyagarajan S, Greter M, Heppner F, Mundt S#, Becher B#. (2023) IL-12 sensing in neurons
induces neuroprotective CNS tissue adaptation and attenuates neuroinflammation in mice. Nature Neuroscience. 

Ulutekin C*, Galli E*, Schreiner B, Khademi M, Callegari I, Piehl F, Sanderson N,
Kirschenbaum D, Mundt S, Filippi M, Furlan R, Olsson T, Derfuss T, Ingelfinger F#, Becher B#. (2024) B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis. Cell
Reports Medicine.

Ingelfinger F, Krishnarajah S, Kramer M, Utz SG, Galli E, Lutz M, Zwicky P, Akarca AU,
Jurado NP, Ulutekin C, Bamert D, Widmer CC, Piccoli L, Sallusto F, Núñez NG, Marafioti T,
Schneiter D, Opitz I, Lanzavecchia A, Jung HH, De Feo D, Mundt S, Schreiner B*, Becher B*.(2021) Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathologica. 

Ingelfinger F, Kuiper KL, Ulutekin C, Rindlisbacher L, Mundt S, Gerdes LA, Smolders J,
M van Luijn MM#, Becher B#. (2024) Twin study dissects CXCR3+ memory B cells as non-
heritable feature in multiple sclerosis. Med.

Ingelfinger F*, Sparano C*, Bamert D, Reyes-Leiva D, Sethi A, Rindlisbacher L, Zwicky
P, Kreutmair S, Widmer C, Mundt S, Cortés-Vicente E, Tugues S, Becher B#, Schreiner B#.
(2022) Azathioprine therapy induces selective NK cell Depletion and IFN-γ Deficiency
predisposing to herpes virus reactivation. J Allergy Clin Immunol. 

Rodov A*, Baniadam H*, Zeiser R, Amit I, Yosef N, Wertheimer T#, Ingelfinger F#.
(2025) Towards the Next Generation of Data-Driven Therapeutics Using Spatially Resolved
Single-Cell Technologies and Generative AI. Eur. J. Immunol.  

Note: #, $ or * indicate that authors marked with the same symbols contributed equally to each study.